Matinas BioPharma Holdings (MTNB) EBIT Margin Growth (3y) (2018 - 2022)
Matinas BioPharma Holdings (MTNB) EBIT Margin Growth (3y) (2018 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.75 Bn | 130.90 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.96 Bn | 77.96 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 56.33 Bn | 51.19 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.56 Bn | 28.25 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | -2,649.00 |
| 10 | Matinas BioPharma Holdings | 1.24 Mn | 431,160.46 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 447,611.00 |
| Mar 31, 2021 | -529,478.00 |
| Dec 31, 2020 | 2.06 Mn |
| Sep 30, 2020 | 174,155.00 |
| Jun 30, 2018 | -67,192.00 |
| Mar 31, 2018 | -930,812.00 |